Background: Distinguishing between stroke subtypes and knowing the time of stroke onset
are critical in clinical practice. Thrombolysis and thrombectomy are very effective treatments …

Stroke is one of the leading causes of disability worldwide. Early diagnosis and treatment of
stroke are important for better clinical outcome. Rapid and accurate diagnosis of stroke …

Identification of reliable and accessible biomarkers to characterize ischemic stroke patients'
prognosis remains a clinical challenge. Neurofilament light chain (NfL) and glial fibrillary …

Introduction Coronavirus disease 2019 (COVID-19) is prevalent among young people, and
neurological involvement has been reported. We investigated neurological symptoms …

Cerebrovascular injury frequently occurs in children with sickle cell anaemia (SCA). Limited
access to magnetic resonance imaging and angiography (MRI‐MRA) in sub‐Saharan Africa …

The utility of serum glial fibrillary acidic protein (GFAP) in acute ischemic stroke (AIS) has
been extensively studied in recent years. Here, we aimed to assess its potential role as a …

Introduction Despite a high burden of stroke, access to rapid brain imaging is limited in many
middle-and low-income countries. Previous studies have described the astroglial protein …

Introduction The post-COVID-19 condition (PCC) is characterized by debilitating persistent
symptoms, including symptoms suggesting neurological aberrations such as concentration …

Introduction Intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) are well-
established, evidence-based, time-critical therapies that reduce morbidity and mortality in …

Acquired brain injury is an urgent situation that requires rapid diagnosis and treatment.
Magnetic resonance imaging (MRI) and computed tomography (CT) are required for …